At a glance
- Originator Taisho Pharmaceutical
- Class Acetates; Antipruritics; Cyclohexanes; Sulfhydryl compounds
- Mechanism of Action Prostanoid DP1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 30 Jul 2010 Development discontinued (phase II) for Atopic dermatitis (topical) during 2010
- 30 Jul 2010 Development discontinued (phase II) for Atopic dermatitis (topical) in Japan during 2010
- 07 Jul 2010 Phase II development is ongoing in Japan